Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, Mantle-Cell × Steroids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Myasthenia Gravis 2 Hemangioma 2 Breast Neoplasms 2 Spinal Cord Compression 1 Radiation Injuries 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Hepatitis 1 Head and Neck Neoplasms 1 Gallstones 1 Esophageal Stenosis 1 Esophageal Neoplasms 1 Common Bile Duct Neoplasms 1 Common Bile Duct Diseases 1 Colorectal Neoplasms 1 Chemical and Drug Induced Liver Injury 1 Carcinoma, Hepatocellular 1 Brain Injuries 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Rituximab 148 Cyclophosphamide 148 fludarabine phosphate 83 Peripheral Blood Stem Cell Transplantation 75 Filgrastim 64 Whole-Body Irradiation 56 Mycophenolic Acid 56 Etoposide 55 Cytarabine 52 Cyclosporine 49 Melphalan 42 Radiotherapy 39 Lenalidomide 39 Tacrolimus 37 ibrutinib 36 fludarabine 36 Busulfan 35 Bortezomib 35 Methotrexate 34 Bendamustine Hydrochloride 33 Antilymphocyte Serum 33 Vincristine 31 Doxorubicin 30 Dexamethasone 30 Carmustine 30 Prednisone 23 Granulocyte Colony-Stimulating Factor 23 Cord Blood Stem Cell Transplantation 23 venetoclax 20 obinutuzumab 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00946374 2009-07-27

HD-MCL2003

Heidelberg University

Phase 2 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡